Champagnie scores 27 to carry St. John's past Xavier 86-73
Published Feb. 16, 2022 9:32 p.m. ET
Associated Press
CINCINNATI (AP) — Julian Champagnie scored 27 points and Tareq Coburn scored 13 points and St. John's beat Xavier 86-73 on Wednesday night.
Aaron Wheeler added 11 points and eight rebounds and Montez Mathis scored 10 for St. John’s (14-11, 6-8 Big East Conference).
Jack Nunge had 22 points and seven rebounds for the Musketeers (17-8, 7-7). Paul Scruggs added 16 points. Zach Freemantle had 10 points.
___
For more AP college basketball coverage:
___
This was generated by Automated Insights,
share
recommended
Last Night in College Basketball: Iowa State, Iowa Played a Wild Back-And-Forth
Top 25 college athletes with highest NIL valuations
4 Takeaways From No. 5 UConn's 71-63 Win Over Texas
2025-26 Men's March Madness Odds: Michigan Becomes New Favorite
Purdue HC Matt Painter on Losing No. 1 Ranking: 'It Really Isn't That Important'
115-Year-Old Boston Arena Where Babe Ruth Played Hockey — Yes, Hockey — Closing
Last Night in College Basketball: No. 10 Iowa State Passes Test vs. No. 11 Iowa
College Basketball Top 10, Bubble Team NET Rankings: Michigan, UConn are No. 1
Top 10 men's college basketball players with highest NIL valuations
Item 1 of 3
recommended
Last Night in College Basketball: Iowa State, Iowa Played a Wild Back-And-Forth
Top 25 college athletes with highest NIL valuations
4 Takeaways From No. 5 UConn's 71-63 Win Over Texas
2025-26 Men's March Madness Odds: Michigan Becomes New Favorite
Purdue HC Matt Painter on Losing No. 1 Ranking: 'It Really Isn't That Important'
115-Year-Old Boston Arena Where Babe Ruth Played Hockey — Yes, Hockey — Closing
Last Night in College Basketball: No. 10 Iowa State Passes Test vs. No. 11 Iowa
College Basketball Top 10, Bubble Team NET Rankings: Michigan, UConn are No. 1
Top 10 men's college basketball players with highest NIL valuations
Item 1 of 3
FOX SPORTS™, SPEED™, SPEED.COM™ & © 2025 Fox Media LLC
and Fox Sports Interactive Media, LLC. All rights reserved. Use of this
website (including any and all parts and components) constitutes your
acceptance of these
Terms of Use and Privacy Policy | Advertising Choices | Your Privacy Choices | Closed Captioning
